CardioKinetix

The Company, based in Menlo Park, CA, has developed a novel transcatheter implant called the Parachute® Ventricular Partitioning Device (Parachute). The Parachute intends to treat heart failure resulting from a heart attack in patients worldwide by improving overall cardiac function.
Company growth
Type
Private
HQ
Menlo Park, US
Founded
2003
Size (employees)
38 (est)-9%
CardioKinetix was founded in 2003 and is headquartered in Menlo Park, US

Key People at CardioKinetix

Maria Sainz

Maria Sainz

President & CEO & Board Director
Brett Hale

Brett Hale

CFO
Jodie Fam

Jodie Fam

VP - Europe
Bob Nicholas

Bob Nicholas

VP, Operations
Jennifer Mateus

Jennifer Mateus

VP, Regulatory Affairs & Quality Assurance
Thomas M. Engels

Thomas M. Engels

VP, Clinical Affairs

CardioKinetix Office Locations

CardioKinetix has office in Menlo Park
Menlo Park, US

CardioKinetix Metrics

CardioKinetix Summary

We estimate that CardioKinetix's latest funding round in December 2014 was $50 M. In total, CardioKinetix has raised $136 M

CardioKinetix Company Life